Rennova Health (RNVA) Stock Price, News & Analysis

Rennova Health saw a increase in short interest in March. As of March 15th, there was short interest totaling 2,934,100 shares, an increase of 186.4% from the February 29th total of 1,024,600 shares. Based on an average daily volume of 109,878,000 shares, the days-to-cover ratio is presently 0.0 days.
View Rennova Health's Short Interest.

Rennova Health, Inc. (OTCMKTS:RNVA) announced its earnings results on Tuesday, August, 14th. The company reported $2,500,000,000.00 earnings per share (EPS) for the quarter. The company earned $3.29 million during the quarter. Rennova Health had a net margin of 11.61% and a negative trailing twelve-month return on equity of 8.49%.

Rennova Health shares reverse split before market open on Wednesday, March 16th 2022. The 1-10000 reverse split was announced on Wednesday, March 16th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 16th 2022. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Rennova Health investors own include Neovasc (NVCN), Himax Technologies (HIMX), Precipio (PRPO), LadRx (CYTR), Heat Biologics (HTBX), Biopharmx (BPMX), Delcath Systems (DCTHD), Immune Pharmaceuticals (IMNP),

Shares of RNVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.